Rianne van den Ham

Rianne van den Ham was trained as a pharmacist and epidemiologist at Utrecht University. During her study she developed an interest for pharmacoepidemiology and pharmaceutical policy making and was given the opportunity to do a research internship at the World Health Organization (WHO), Geneva on Essential Medicines under the supervision of Richard Laing. After graduation, she temporarily worked as a pharmacist in the pharmacy of the St. Antonius Hospital, Nieuwegein.

In 2011 she started as a PhD student at the Division of Pharmacoepidemiology and Clinical Pharmacology of the Utrecht Institute for Pharmaceutical Sciences, The Netherlands, supervised by Prof. Bert Leufkens, Prof. Tjeerd van Staa and Prof. Olaf Klungel. Rianne combined her position as a PhD-student with teaching in the European Program for Pharmacovigilance and Pharmacoepidemiology (Eu2P) in the field of medicines benefit-risk assessment. She completed her thesis in 2016 entitled: “Benefits and risks for the individual: anticoagulation for patients with atrial fibrillation”. From May 2017 untill September 2019 she worked as a postdoctoral researcher for the Prince Claus Chair of Development and Equity for the theme Affordable (Bio)Therapeutics for Public Health, in collaboration with Prof. Fatima Suleman (University of KwaZulu-Natal). She is now working as an assistant professor for the Utrecht Centre for Pharmaceutical Policy and Regulation. Her research focusses on pricing policies, indicators for measuring access and evidence based policy making.